Comprehensive kinetic analysis and influence of reaction components for chlorzoxazone 6-hydroxylation in human liver microsomes with CYP antibodies.
Yamamura Y, Koyama N, Umehara K.
Xenobiotica · journal article · DOI 10.3109/00498254.2014.985760 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för chlorzoxazone. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
11 träffarPharmacokinetics of a cytochrome P450 2E1 probe, chlorzoxazone, and its 6-hydroxy metabolite in poloxamer 407-induced hyperlipidemic rats.
Kwon MH, Lee CJ, Cho YY, Kang HE.
J Pharm Pharm Sci · research support, non-u.s. gov't; journal article · DOI 10.18433/j3dw3sEffect of chlorzoxazone in patients with downbeat nystagmus: a pilot trial.
Feil K, Claaßen J, Bardins S, Teufel J, Krafczyk S, Schneider E, Schniepp R, Jahn K, Kalla R, Strupp M.
Neurology · research support, non-u.s. gov't; journal article · DOI 10.1212/wnl.0b013e3182a55f6dChlorzoxazone, an SK-type potassium channel activator used in humans, reduces excessive alcohol intake in rats.
Hopf FW, Simms JA, Chang SJ, Seif T, Bartlett SE, Bonci A.
Biol Psychiatry · research support, non-u.s. gov't; research-article; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1016/j.biopsych.2010.11.011A study on the pharmacokinetics of chlorzoxazone in healthy Thai volunteers.
Prompila N, Wittayalertpanya S, Komolmit P.
J Med Assoc Thai · research support, non-u.s. gov't; journal articleChlorzoxazone inhibits contraction of rat thoracic aorta.
Dong DL, Luan Y, Feng TM, Fan CL, Yue P, Sun ZJ, Gu RM, Yang BF.
Eur J Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ejphar.2006.06.063In vivo and in vitro characterization of chlorzoxazone metabolism and hepatic CYP2E1 levels in African Green monkeys: induction by chronic nicotine treatment.
Lee AM, Yue J, Tyndale RF.
Drug Metab Dispos · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1124/dmd.106.010363Conformational changes in nitric oxide synthases induced by chlorzoxazone and nitroindazoles: crystallographic and computational analyses of inhibitor potency.
Rosenfeld RJ, Garcin ED, Panda K, Andersson G, Aberg A, Wallace AV, Morris GM, Olson AJ, Stuehr DJ, Tainer JA, Getzoff ED.
Biochemistry · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1021/bi026313jChlorzoxazone: a probe drug the metabolism of which can be used to monitor one-point blood sampling in the carbon tetrachloride-intoxicated rat.
Tanaka E.
Hum Exp Toxicol · journal article · DOI 10.1191/096032701682692937Stimulation of Cl(-) secretion by chlorzoxazone.
Singh AK, Devor DC, Gerlach AC, Gondor M, Pilewski JM, Bridges RJ.
J Pharmacol Exp Ther · comparative study; research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1016/s0022-3565(24)35351-0Pharmacokinetics of chlorzoxazone in humans.
Desiraju RK, Renzi NL, Nayak RK, Ng KT.
J Pharm Sci · journal article · DOI 10.1002/jps.2600720905